| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |